Abstract
Lymph node dissemination is a major prognostic factor in human cancer. However, the molecular mechanisms underlying lymph node metastasis are poorly understood. Recently, vascular endothelial growth factor-C (VEGF-C) was identified as a ligand for VEGF receptor-3 (VEGFR-3/Flt-4) and the expression of VEGFR-3 was found to be highly restricted to the lymphatic endothelial cells. In this report, we investigated the expression of VEGF-C and VEGFR-3 in human prostatic carcinoma tissue by using in situ hybridization and immunohistochemical staining respectively. Expression of VEGF-C mRNA in prostatic carcinoma was significantly higher in lymph node-positive group than in lymph node-negative group. In addition, the number of VEGFR-3-positive vessels was increased in stroma surrounding VEGF-C-positive prostatic carcinoma cells. These results suggest that the expression of VEGF-C in prostatic carcinoma cells is implicated in the lymph node metastasis.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Achen, M. G., Jeltsch, M., Kukk, E., Makinen, T., Vitali, A., Wilks, A. F., Alitalo, K. & Stacker, S. A. (1998) Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor-2 (Flk1) and VEGF receptor-3 (Flt-4). Proc Natl Acad Sci USA 95: 548–553.
Adams, J. C. (1981) Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 29: 775
Barleon, B., Sozzani, S., Zhou, D., Weich, H., Mantovani, A. & Marmé, D. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336–3343.
Clauss, M., Weich, H., Breier, G., Knies, U., Rock, W., Waltenberger, J. & Risau, W. (1996) The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem 271: 17629–17634.
Dvorak, H. F., Brown, L. F., Detmar, M. & Dvorak, A. M. (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular permeability, and angiogenesis. Am J Pathol 146: 1029–1039.
Epstein, J. I., Partin, A. W., Sauvageot, J. & Walsh, P. C. (1996) Prediction of progression following radical prostatectomy: a multivariate analysis of 721 men with long-term follow-up. Am J Surg Pathol 20: 286–292.
Ferrara, N. & Davis-Smyth, T. (1997) The biology of vascular endothelial growth factor. Endocrine Rev 18: 4–25.
Folkman, J. & Shing, Y. (1992) Angiogenesis. J Biol Chem 267: 10931–10934.
Fong, G-H, Rossant, J., Gertenstein, M. & Breitman, M. (1995) Role of Flt-1 receptor tyrosine kinase in regulation of assembly of vascular endothelium. Nature 376: 66–67.
Gleason, D. F. (1977). Histologic grading and clinical staging of prostatic carcinoma. In Urologic Pathology: Prostate, Tannenbaum M (ed), pp. 171–198. Lea & Febiger, Philadelphia
Jeltsch, M., Kaipainen, A., Joukov, V., Meng, X., Lakso, M., Rauvala, H., Swartz, M., Fukumura, D., Jain, R. K. & Alitaro, K. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423–1425.
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N. & Alitalo, K. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt-4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15: 290–298.
Jussila, L., Valtola, R., Partanen, T. A., Salven, P., Heikkilä, P., Matikainen, M-T, Renkonen, R., Kaipainen, A., Detmar, M., Tschachler, E., Alitalo, R. & Alitalo, K. (1998) Lymphatic endothelium and Kaposi’s sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res 58: 1599–1604.
Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W. M., Fang, G-H, Dumont, D., Beitman, M. & Alitalo, K. (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 92: 3566–3570.
Koji, T. & Nakane, P. K. (1996) Recent advances in molecular histochemical techniques: in situ hybridization and southwestern histochemistry. J Electron Microsc 45: 119–127.
Oh, S-J, Jeltsch, M., Birkenhäger, R., McCarthy, J. E. G., Weich, H. A., Christ, B., Alitaro, K. & Wilting, J. (1997) VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol 188: 96–109.
Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R. & Alitalo, K. (1992) FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines. Cancer Res 52: 5738–5743.
Shalabi, F., Rossant, J., Yamaguchi, T. P., Gertenstein, M., Wu, X-F, Breitman, M. L. & Schuh, A. C. (1995) Failure of blood island formation and vasculogenesis in Flk-1 dificient mice. Nature 376: 62–66.
Slack, N. H., Lane, W. W., Priore, R. L. & Murphy, G. P. (1986) Prostatic cancer treated at a categorical center, 1980–1983. Urology 27: 205–213.
Steiner, M. S. (1993) Role of peptide growth factors in the prostate: a review. Urology 42: 99–110.
Tsurusaki, T., Koji, T., Sakai, H., Kanetake, H., Nakane, P. K. & Saito, Y. (1998) Cellular expression of beta-microseminoprotein (β-MSP) mRNA and its protein in untreated prostate cancer. Prostate 35: 109–116.
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. & Heldin, C-H (1994) Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J Biol Chem 269: 26988–26995.
Yoshii, A., Koji, T., Ohsawa, N. & Nakane, P. K. (1995) In situ localization of ribosomal RNAs in a reliable reference for hybridizable RNA in tissue sections. J Histochem Cytochem 43: 321–327.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Tsurusaki, T., Kanda, S., Sakai, H. et al. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 80, 309–313 (1999). https://doi.org/10.1038/sj.bjc.6690356
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690356
Keywords
This article is cited by
-
In vivo and in vitro effect of hepatocarcinoma lymph node metastasis by upregulation of Annexin A7 and relevant mechanisms
Tumor Biology (2016)
-
Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway
Cell Communication and Signaling (2014)
-
Neither expression of VEGF-C/D nor lymph vessel density supports lymphatic invasion as the mechanism responsible for local spread of recurrent salivary pleomorphic adenoma
Virchows Archiv (2014)
-
Immunohistochemical expression of PDGFR, VEGF-C, and proteins of the mToR pathway before and after androgen deprivation therapy in prostate carcinoma: significant decrease after treatment
Targeted Oncology (2014)
-
Wie entwickeln sich Metastasen urologischer Tumoren?
Der Urologe (2014)